Eli Lilly and Company (LLY) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

Eli Lilly and Company shareholders at a glance

The largest holder of Eli Lilly and Company stock is Lilly Endowment, Inc., with 90.4 million shares (9.60% of the company), worth about $105.00 billion as of September 25, 2026. The 10 largest holders together own 49.1%.

In Q2 2026, 4,881 institutional holdings reports listed shares worth $946.00 billion.

Insiders reported 129 transactions in the last two years: 30 sales worth $2.31 billion and 8 purchases. The newest one on file is from September 21, 2026 (Sulzberger Gabrielle, Director).

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through September 21, 2026.

LLY logo

Eli Lilly and Company

LLYUnited States
Healthcare

Shareholders Summary

2026Q2

Filings
4881
Options Value
$36.90B
Value (excl. Options)
$946.00B
Shares (excl. Options)
-

Ownership by Type

Geographic Distribution

Largest Eli Lilly and Company shareholders

HolderShares% of companyValue
Lilly Endowment, Inc.90.4 million9.60%$105.0B
Lilly Endowment, Inc.90.4 million9.60%$105.0B
Vanguard Capital Management LLC53.5 million5.69%$61.9B
PNC Wealth Management LLC51.1 million5.43%$59.1B
BlackRock Advisors LLC50.4 million5.35%$58.3B
State Street Corporation36.2 million3.85%$41.9B
Fidelity Management & Research Co. LLC28.4 million3.02%$32.9B
Capital Research & Management Co. (Global Investors)20.9 million2.22%$24.1B
Vanguard Portfolio Management LLC20.9 million2.22%$24.1B
Geode Capital Management LLC20.3 million2.16%$23.5B

As of September 25, 2026.

Eli Lilly and Company institutional holdings by quarter

QuarterReportsSharesValue
Q2 20264,881–$946.0B
Q1 20264,610778.0 million$713.0B
Q4 20254,683795.0 million$847.0B
Q3 20254,161777.0 million$592.0B
Q2 20254,157789.0 million$614.0B
Q1 20254,145838.0 million$691.0B
Q4 20244,114783.0 million$604.0B
Q3 20243,863811.0 million$705.0B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Eli Lilly and Company insider trades

InsiderDateTitleTransactionValue
Sulzberger GabrielleSep 21, 2026DirectorStock Award(Grant) at price 1164.89 per share.$4,958
Luciano Juan RSep 21, 2026DirectorStock Award(Grant) at price 1164.89 per share.$15,917
Alvarez RalphSep 21, 2026DirectorStock Award(Grant) at price 1164.89 per share.$12,417
Fyrwald J. ErikSep 21, 2026DirectorStock Award(Grant) at price 1164.89 per share.$9,917
Seymour MelissaSep 9, 2026OfficerStock Gift at price 0.00 per share.–
Hernandez EdgardoSep 2, 2026OfficerStock Gift at price 0.00 per share.–
Dozier EricSep 2, 2026OfficerStock Gift at price 0.00 per share.–
Sulzberger GabrielleAug 17, 2026DirectorStock Award(Grant) at price 1183.16 per share.$4,958
Luciano Juan RAug 17, 2026DirectorStock Award(Grant) at price 1183.16 per share.$15,917
Jonsson PatrikAug 17, 2026OfficerSale at price 1175.10 per share.$7.6M
Alvarez RalphAug 17, 2026DirectorStock Award(Grant) at price 1183.16 per share.$12,417
Fyrwald J. ErikAug 17, 2026DirectorStock Award(Grant) at price 1183.16 per share.$9,917

Newest 12 of 129 insider transactions in the last two years.

Questions and answers

Who owns the most Eli Lilly and Company stock?

Lilly Endowment, Inc., with 9.60% of the company (as of September 25, 2026). Next: Lilly Endowment, Inc. (9.60%) and Vanguard Capital Management LLC (5.69%).

How many institutions own Eli Lilly and Company stock?

4,881 institutional holdings reports listed Eli Lilly and Company shares in Q2 2026 worth $946.00 billion.

Are Eli Lilly and Company insiders buying or selling the stock?

In the last two years insiders reported 30 sales and 8 purchases (129 transactions in all); the newest on file is from September 21, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube